Conference abstract
Nanotechnology: Formulation, scale-up and cGMP manufacture for clinical investigation
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Recently research work in the field of parenteral nanotechnologies has shown that many nano-objects of therapeutic interest, including (nano-crystalline suspension, emulsion, liposomes, polymeric nano-particles) can be manufactured using high pressure homogenization. Most of these studies however are focused on exploratory research activities. Amongst the hurdles to test these nano-objects in a clinical research setting and eventually reach the market are the design of stable commercial formulation, process scale-up and cGMP manufacturing in aseptic environment. Sanofi has developed a unique technology platform to support the formulation, manufacture and supply of nanotechnology based projects from preclinical, through clinical to industrialization and launch. In the present communication the author will focus on the presentation of 3 key areas of this platform: ? A physico-chemical based approach to formulation and process engineering ? Process development and scale-up ? Parenteral cGMP pilot facilities designed to accommodate highly active product, and operate at high pressure and high temperature. This pilot line is able to supply batches from hundreds of grams to a few kilogrammes of nano-crystalline suspension, nano-emulsion or liposomes.
Keywords
Subjects
NanotechnologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Nanomedicine & Nanotechnology
- SubjectNanotechnology
- BylineArticles whose byline prints “Mostafa Nakach”
- BylineArticles whose byline prints “Jean-Ren? Authelin”
